Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
SHC3 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 3.38E4 | Evidence | |||||
SHC3 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 2.47E4 | Evidence | |||||
SHC3 | DDR1 | DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE: Epithelial discoidin domain-con | 1.11E4 | Evidence | |||||
SHC3 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 8.52E3 | Evidence | |||||
SHC3 | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 7.70E3 | Evidence | |||||
SHC3 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 6.62E3 | Evidence | |||||
SHC3 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 6.36E3 | Evidence | |||||
SHC3 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 6.15E3 | Evidence | |||||
SHC3 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 5.60E3 | Evidence | |||||
SHC3 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 2.27E3 | Evidence | |||||
SHC3 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 1.37E3 | Evidence | |||||
SHC3 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 1.25E3 | Evidence | |||||
SHC3 | VAV1 | VAV1, VAV: Proto-oncogene vav | 1.06E3 | Evidence | |||||
SHC3 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 1.04E3 | Evidence | |||||
SHC3 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 945.0 | Evidence | |||||
SHC3 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 824.0 | Evidence | |||||
SHC3 | SOS1 | SOS1: Son of sevenless homolog 1 | 743.0 | Evidence | |||||
SHC3 | CRKL | CRKL: Crk-like protein | 688.0 | Evidence | |||||
SHC3 | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 150.0 | Evidence | |||||
SHC3 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 98.7 | Evidence | |||||
SHC3 | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 64.80 | Evidence | |||||
SHC3 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 58.40 | Evidence | |||||
SHC3 | HCK | N/A | 58.40 | Evidence | |||||
SHC3 | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 57.40 | Evidence | |||||
SHC3 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 53.20 | Evidence | |||||
SHC3 | LTK | LTK, TYK1: Leukocyte tyrosine kinase receptor precursor | 53.20 | Evidence | |||||
SHC3 | INSR | INSR: Insulin receptor precursor | 53.20 | Evidence | |||||
SHC3 | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 50.10 | Evidence | |||||
SHC3 | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 44.50 | Evidence | |||||
SHC3 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 32.90 | Evidence | |||||
SHC3 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 28.30 | Evidence | |||||
SHC3 | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 25.90 | Evidence | |||||
SHC3 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 25.90 | Evidence | |||||
SHC3 | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 25.90 | Evidence | |||||
SHC3 | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 24.10 | Evidence | |||||
SHC3 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 23.90 | Evidence | |||||
SHC3 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 23.50 | Evidence | |||||
SHC3 | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 23.20 | Evidence | |||||
SHC3 | MET | MET: Hepatocyte growth factor receptor precursor | 22.50 | Evidence | |||||
SHC3 | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 21.60 | Evidence | |||||
SHC3 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 21.60 | Evidence | |||||
SHC3 | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 17.70 | Evidence | |||||
SHC3 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 17.30 | Evidence | |||||
SHC3 | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 17.30 | Evidence | |||||
SHC3 | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 17.30 | Evidence | |||||
SHC3 | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 15.20 | Evidence | |||||
SHC3 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 15.10 | Evidence | |||||
SHC3 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 14.20 | Evidence | |||||
SHC3 | JAK1 | 12.70 | Evidence | ||||||
SHC3 | SYK | SYK: Tyrosine-protein kinase SYK | 12.70 | Evidence | |||||
SHC3 | ABR | ABR: Active breakpoint cluster region-related protein | 9.95 | Evidence | |||||
SHC3 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 9.16 | Evidence | |||||
SHC3 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 6.64 | Evidence | |||||
SHC3 | GRAP | GRAP: GRB2-related adapter protein | 6.54 | Evidence | |||||
SHC3 | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 5.89 | Evidence | |||||
SHC3 | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 5.30 | Evidence | |||||
SHC3 | ROBO1 | N/A | 4.80 | Evidence | |||||
SHC3 | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 4.56 | Evidence | |||||
SHC3 | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 4.34 | Evidence | |||||
SHC3 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 4.27 | Evidence | |||||
SHC3 | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 4.01 | Evidence | |||||
SHC3 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 3.70 | Evidence | |||||
SHC3 | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 3.6 | Evidence | |||||
SHC3 | EREG | EREG: Proepiregulin precursor [Contains: Epiregulin | 3.58 | Evidence | |||||
SHC3 | MAP2K7 | MAP2K7, JNKK2, MEK7, MKK7, PRKMK7: Dual specificity mitogen-activated protein ki | 3.41 | Evidence | |||||
SHC3 | STAT3 | 3.31 | Evidence | ||||||
SHC3 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 3.31 | Evidence | |||||
SHC3 | VAV3 | VAV3: Protein vav-3 | 3.24 | Evidence | |||||
SHC3 | ASB17 | ASB17: Ankyrin repeat and SOCS box protein 17 | 3.18 | Evidence | |||||
SHC3 | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 3.18 | Evidence | |||||
SHC3 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 3.18 | Evidence | |||||
SHC3 | CD160 | CD160, BY55: CD160 antigen precursor | 3.15 | Evidence | |||||
SHC3 | AREG | AREG, SDGF: Amphiregulin precursor | 3.15 | Evidence | |||||
SHC3 | TGFA | TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow | 3.15 | Evidence | |||||
SHC3 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 3.05 | Evidence | |||||
SHC3 | CTTN | CTTN, EMS1: Src substrate cortactin | 2.93 | Evidence | |||||
SHC3 | PTPRS | PTPRS: Receptor-type tyrosine-protein phosphatase S precursor | 2.91 | Evidence | |||||
SHC3 | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 2.85 | Evidence | |||||
SHC3 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 2.76 | Evidence | |||||
SHC3 | BTC | BTC: Probetacellulin precursor [Contains: Betacellulin | 2.68 | Evidence | |||||
SHC3 | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 2.63 | Evidence | |||||
SHC3 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 2.63 | Evidence | |||||
SHC3 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 2.60 | Evidence | |||||
SHC3 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 2.50 | Evidence | |||||
SHC3 | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 2.50 | Evidence | |||||
SHC3 | LAT | LAT: Linker for activation of T-cells family member 1 | 2.50 | Evidence | |||||
SHC3 | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 2.50 | Evidence | |||||
SHC3 | PLD2 | PLD2: Phospholipase D2 | 2.47 | Evidence | |||||
SHC3 | PLD1 | PLD1: Phospholipase D1 | 2.47 | Evidence | |||||
SHC3 | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 2.47 | Evidence | |||||
SHC3 | IRS2 | IRS2: Insulin receptor substrate 2 | 2.37 | Evidence | |||||
SHC3 | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 2.37 | Evidence | |||||
SHC3 | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 2.24 | Evidence | |||||
SHC3 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 2.19 | Evidence | |||||
SHC3 | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 2.19 | Evidence | |||||
SHC3 | MDN1 | MDN1, KIAA0301: Midasin | 2.18 | Evidence | |||||
SHC3 | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 2.17 | Evidence | |||||
SHC3 | DAB1 | DAB1: Disabled homolog 1 | 2.13 | Evidence | |||||
SHC3 | MAPK12 | MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 | 2.13 | Evidence | |||||
SHC3 | APS | SH2B2, APS: SH2B adapter protein 2 | 2.13 | Evidence | |||||
SHC3 | VIL2 | N/A | 1.96 | Evidence | |||||
SHC3 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 1.96 | Evidence | |||||
SHC3 | DCC | DCC: Netrin receptor DCC precursor | 1.94 | Evidence | |||||
SHC3 | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 1.91 | Evidence | |||||
SHC3 | EGF | EGF: Pro-epidermal growth factor precursor | 1.91 | Evidence | |||||
SHC3 | CEACAM1 | CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr | 1.91 | Evidence | |||||
SHC3 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 1.91 | Evidence | |||||
SHC3 | CD2AP | CD2AP: CD2-associated protein | 1.90 | Evidence | |||||
SHC3 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 1.90 | Evidence | |||||
SHC3 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 1.89 | Evidence | |||||
SHC3 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 1.89 | Evidence | |||||
SHC3 | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 1.89 | Evidence | |||||
SHC3 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 1.89 | Evidence | |||||
SHC3 | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 1.87 | Evidence | |||||
SHC3 | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 1.87 | Evidence | |||||
SHC3 | F12 | F12: Coagulation factor XII precursor | 1.78 | Evidence | |||||
SHC3 | AMBP | AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin | 1.78 | Evidence | |||||
SHC3 | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 1.74 | Evidence | |||||
SHC3 | HBEGF | HBEGF, DTR, DTS, HEGFL: Proheparin-binding EGF-like growth factor precursor [Con | 1.72 | Evidence | |||||
SHC3 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 1.69 | Evidence | |||||
SHC3 | DAB2 | DAB2, DOC2: Disabled homolog 2 | 1.69 | Evidence | |||||
SHC3 | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 1.69 | Evidence | |||||
SHC3 | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 1.64 | Evidence | |||||
SHC3 | EPOR | EPOR: Erythropoietin receptor precursor | 1.64 | Evidence | |||||
SHC3 | GHR | GHR: Growth hormone receptor precursor | 1.64 | Evidence | |||||
SHC3 | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 1.64 | Evidence | |||||
SHC3 | ITGB4 | N/A | 1.64 | Evidence | |||||
SHC3 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 1.62 | Evidence | |||||
SHC3 | SYNJ1 | SYNJ1, KIAA0910: Synaptojanin-1 | 1.61 | Evidence | |||||
SHC3 | IRS1 | IRS1: Insulin receptor substrate 1 | 1.59 | Evidence | |||||
SHC3 | TNC | TNC, HXB: Tenascin precursor | 1.54 | Evidence | |||||
SHC3 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 1.54 | Evidence | |||||
SHC3 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 1.54 | Evidence | |||||
SHC3 | CD58 | CD58, LFA3: Lymphocyte function-associated antigen 3 precursor | 1.48 | Evidence | |||||
SHC3 | SCML2 | SCML2: Sex comb on midleg-like protein 2 | 1.48 | Evidence | |||||
SHC3 | CD3D | CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor | 1.48 | Evidence | |||||
SHC3 | SOS2 | SOS2: Son of sevenless homolog 2 | 1.47 | Evidence | |||||
SHC3 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 1.45 | Evidence | |||||
SHC3 | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 1.43 | Evidence | |||||
SHC3 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 1.29 | Evidence | |||||
SHC3 | PROZ | PROZ: Vitamin K-dependent protein Z precursor | 1.22 | Evidence | |||||
SHC3 | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 1.17 | Evidence | |||||
SHC3 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 1.13 | Evidence | |||||
SHC3 | MET | N/A | 1.07 | Evidence | |||||
SHC3 | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 1.02 | Evidence | |||||
SHC3 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 1.01 | Evidence |